Waystar Reports Third Quarter 2024 Results
Revenue growth of 22% year-over-year
Net income of
Net income margin of 2%; Adjusted EBITDA margin of 40%
"Waystar delivered another quarter of strong top-line growth," said
Third Quarter 2024 Financial Highlights
- Revenue of
$240.1 million , up 22% year-over-year - Net income of
$5.4 million , GAAP net income per share of$0.03 , and net income margin of 2% - Non-GAAP net income of
$25.3 million and non-GAAP net income per diluted share of$0.14 - Adjusted EBITDA of
$96.7 million and Adjusted EBITDA margin of 40% - Cash flow from operations of
$79 million and Unlevered Free Cash Flow of$89 million
Key Metrics and Revenue Disaggregation
- 1,173 clients contributed over
$100,000 in LTM revenue, up 14% year-over-year - A net revenue retention rate (NRR) of 109%
- Subscription revenue of
$118.0 million , up 16% year-over-year - Volume-based revenue of
$120.7 million , up 28% year-over-year
Financial Outlook
As of
- Total revenue is expected to be between
$926 million and$934 million - Adjusted EBITDA is expected to be between
$374 million and$378 million - Non-GAAP net income is expected to be between
$47 million and$50 million - Diluted non-GAAP net income per share is expected to be between
$0.30 and$0.32
Webcast Information
Waystar's financial results will be discussed on a conference call scheduled at
Non-GAAP Financial Measures
To supplement the consolidated financial statements prepared and presented in accordance with
Adjusted EBITDA, Adjusted EBITDA margin, non-GAAP net income, non-GAAP net income per share and unlevered free cash flow are not recognized terms under GAAP and should not be considered as an alternative to net income (loss) or net income (loss) margin as measures of financial performance or cash provided by operating activities as a measure of liquidity, or any other performance measure derived in accordance with GAAP. Additionally, these measures are not intended to be a measure of free cash flow available for management's discretionary use, as they do not consider certain cash requirements such as interest payments, tax payments, and debt service requirements. The presentations of these measures have limitations as analytical tools and should not be considered in isolation, or as a substitute for analysis of our results as reported under GAAP. Because not all companies use identical calculations, the presentations of these measures may not be comparable to other similarly titled measures of other companies and can differ significantly from company to company. A reconciliation is provided below for our non-GAAP financial measures to the most directly comparable financial measure stated in accordance with GAAP. Investors are encouraged to review the related GAAP financial measures and the reconciliation of non-GAAP financial measures to their most directly comparable GAAP financial measures, and not to rely on any single financial measure to evaluate our business.
The following non-GAAP financial measures and key performance metrics are defined below:
Adjusted EBITDA and Adjusted EBITDA Margin
We define Adjusted EBITDA as net loss before interest expense, net income tax benefit, depreciation and amortization, and as further adjusted for stock-based compensation expense, acquisition and integration costs, asset and lease impairments, costs related to amended debt agreements, and IPO related costs. Adjusted EBITDA margin represents Adjusted EBITDA as a percentage of revenue.
Non-GAAP Net Income and Non-GAAP Net Income Per Share
We define non-GAAP net income as GAAP net income excluding the impact of stock-based compensation, acquisition and integration costs, asset and lease impairments, IPO related costs, and costs related to amended debt agreements. The tax effects of the adjustments are calculated using a management-estimated annual effective non-GAAP tax rate of 21%.
We define non-GAAP net income per share as non-GAAP net income (loss) divided by weighted-average shares used to compute net loss per share.
Unlevered Free Cash Flow
We define unlevered free cash flow as cash from operations plus cash interest expense less capital expenses.
Net Debt
We define net debt as the sum of the current portion of long-term debt, long-term debt, and accounts receivable securitization less cash and equivalents.
Adjusted Net Leverage Ratio
We define adjusted net leverage ratio as net debt divided by adjusted EBITDA over the preceding twelve months.
Key Performance Metrics
Net Revenue Retention Rate
Our Net Revenue Retention Rate compares twelve months of client invoices for our solutions at two period end dates. To calculate our Net Revenue Retention Rate, we first accumulate the total amount invoiced during the twelve months ending with the prior period-end or Prior Period Invoices. We then calculate the total amount invoiced to those same clients for the twelve months ending with the current period-end, or Current Period Invoices. Current Period Invoices are inclusive of upsell, downsell, pricing changes, clients that cancel or chose not to renew, and discontinued solutions with continuing clients. The Net Revenue Retention Rate is then calculated by dividing the Current Period Invoices by the Prior Period Invoices. Our total invoices included in the analysis are greater than 98% of reported revenue. We use Net Revenue Retention Rate to evaluate our ongoing operations and for internal planning and forecasting purposes. Acquired businesses are included in the last-twelve-month Net Revenue Retention Rate in the ninth quarter after acquisition, which is the earliest point that comparable post-acquisition invoices are available for both the current and prior twelve-month period.
Customer Count with >
We regularly monitor and review our count of clients who generate more than
Our count of clients who generate more than
Forward-Looking Statements
This press release contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that reflect our current views with respect to, among other things, statements regarding Waystar's expectations relating to future operating results and financial position, including full year 2024, and future periods; anticipated future expenses and investments; our industry, business strategy, goals, and expectations concerning our market position, future operations, margins, profitability, capital expenditures, liquidity, and capital resources and other financial and operating information. Forward-looking statements include all statements that are not historical facts. These statements may include words such as "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "future," "will," "seek," "foreseeable," "outlook," the negative version of these words or similar terms and phrases to identify forward-looking statements in this press release, including the discussion of outlook for full fiscal year 2024.
The forward-looking statements contained in this press release are based on management's current expectations and are not guarantees of future performance. The forward-looking statements are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. Our expectations, beliefs, and projections are expressed in good faith, and we believe there is a reasonable basis for them. However, there can be no assurance that management's expectations, beliefs, and projections will result or be achieved. The following factors are among those that may cause actual results to differ materially from the forward-looking statements: our operation in a highly competitive industry; our ability to retain our existing clients and attract new clients; our ability to successfully execute on our business strategies in order to grow; our ability to accurately assess the risks related to acquisitions and successfully integrate acquired businesses; our ability to establish and maintain strategic relationships; the growth and success of our clients and overall healthcare transaction volumes; consolidation in the healthcare industry; our selling cycle of variable length to secure new client agreements; our implementation cycle that is dependent on our clients' timing and resources; our dependence on our senior management team and certain key employees, and our ability to attract and retain highly skilled employees; the accuracy of the estimates and assumptions we use to determine the size of our total addressable market; our ability to develop and market new solutions, or enhance our existing solutions, to respond to technological changes, or evolving industry standards; the interoperability, connectivity, and integration of our solutions with our clients' and their vendors' networks and infrastructures; the performance and reliability of internet, mobile, and other infrastructure; the consequences if we cannot obtain, process, use, disclose, or distribute the highly regulated data we require to provide our solutions; our reliance on certain third-party vendors and providers; any errors or malfunctions in our products and solutions; failure by our clients to obtain proper permissions or provide us with accurate and appropriate information; the potential for embezzlement, identity theft, or other similar illegal behavior by our employees or vendors, and a failure of our employees or vendors to observe quality standards or adhere to environmental, social, and governance standards; our compliance with the applicable rules of the
Any forward-looking statements made by us in this press release speak only as of the date of this press release and are expressly qualified in their entirety by the cautionary statements included in this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. You should not place undue reliance on our forward-looking statements. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as may be required by any applicable securities laws.
About Waystar
Waystar's mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves approximately 30,000 clients, representing over 1 million distinct providers, including 18 of 22 institutions on the
|
|
|
|
|
|
|
|
|
|
|
1 |
We have not reconciled the forward-looking Adjusted EBITDA, non- GAAP net income, and non-GAAP net income per share guidance included above to the most directly comparable GAAP measure because this cannot be done without unreasonable effort due to the variability and low visibility with respect to certain costs, the most significant of which are incentive compensation (including stock-based compensation), transaction-related expenses, and certain fair value measurements, which are potential adjustments to future earnings. We expect the variability of these items to have a potentially unpredictable, and a potentially significant, impact on our future GAAP financial results. |
|||||||
|
Waystar Condensed Consolidated Statements of Operations (in thousands, except for share and per share data) (unaudited) |
||||||||||||
|
|
||||||||||||
|
|
|
Three months ended |
|
Nine months ended |
||||||||
|
|
|
2024 |
|
2023 |
|
2024 |
|
2023 |
||||
|
Revenue |
|
$ |
240,112 |
|
$ |
197,263 |
|
$ |
699,447 |
|
$ |
584,315 |
|
Operating expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenue (exclusive of depreciation and amortization expenses) |
|
|
80,545 |
|
|
62,922 |
|
|
236,188 |
|
|
182,578 |
|
Sales and marketing |
|
|
38,450 |
|
|
32,114 |
|
|
117,945 |
|
|
93,490 |
|
General and administrative |
|
|
22,704 |
|
|
17,365 |
|
|
88,794 |
|
|
46,524 |
|
Research and development |
|
|
11,082 |
|
|
8,972 |
|
|
37,303 |
|
|
25,548 |
|
Depreciation and amortization |
|
|
60,185 |
|
|
43,675 |
|
|
148,635 |
|
|
131,780 |
|
Total operating expenses |
|
|
212,966 |
|
|
165,048 |
|
|
628,865 |
|
|
479,920 |
|
Income from operations |
|
|
27,146 |
|
|
32,215 |
|
|
70,582 |
|
|
104,395 |
|
Other expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
(17,752) |
|
|
(50,755) |
|
|
(122,759) |
|
|
(147,047) |
|
Related party interest expense |
|
|
(707) |
|
|
(1,655) |
|
|
(3,425) |
|
|
(6,010) |
|
Income/(loss) before income taxes |
|
|
8,687 |
|
|
(20,195) |
|
|
(55,602) |
|
|
(48,662) |
|
Income tax expense/(benefit) |
|
|
3,274 |
|
|
(4,709) |
|
|
(17,398) |
|
|
(11,743) |
|
Net income/(loss) |
|
$ |
5,413 |
|
$ |
(15,486) |
|
$ |
(38,204) |
|
$ |
(36,919) |
|
Net income/(loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
0.03 |
|
$ |
(0.13) |
|
$ |
(0.27) |
|
$ |
(0.30) |
|
Diluted |
|
$ |
0.03 |
|
$ |
(0.13) |
|
$ |
(0.27) |
|
$ |
(0.30) |
|
Weighted-average shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
171,578,311 |
|
|
121,673,852 |
|
|
142,367,458 |
|
|
121,674,189 |
|
Diluted |
|
|
176,181,511 |
|
|
121,673,852 |
|
|
142,367,458 |
|
|
121,674,189 |
|
Waystar Condensed Consolidated Balance Sheets (in thousands, except for share and per share data) (unaudited) |
||||||
|
|
||||||
|
|
|
|
|
|
||
|
|
|
(Unaudited) |
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
127,125 |
|
$ |
35,580 |
|
Restricted cash |
|
|
17,222 |
|
|
9,848 |
|
Accounts receivable, net of allowance of |
|
|
137,893 |
|
|
126,089 |
|
Income tax receivable |
|
|
4,584 |
|
|
6,811 |
|
Prepaid expenses |
|
|
14,294 |
|
|
13,296 |
|
Other current assets |
|
|
4,315 |
|
|
30,426 |
|
Total current assets |
|
|
305,433 |
|
|
222,050 |
|
Property, plant and equipment, net |
|
|
48,017 |
|
|
61,259 |
|
Operating lease right-of-use assets, net |
|
|
10,214 |
|
|
10,353 |
|
Intangible assets, net |
|
|
1,069,696 |
|
|
1,186,936 |
|
|
|
|
3,019,826 |
|
|
3,030,013 |
|
Deferred costs |
|
|
80,667 |
|
|
65,811 |
|
Other long-term assets |
|
|
6,694 |
|
|
6,552 |
|
Total assets |
|
$ |
4,540,547 |
|
$ |
4,582,974 |
|
Liabilities and stockholders' equity |
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
Accounts payable |
|
$ |
47,840 |
|
$ |
45,484 |
|
Accrued compensation |
|
|
27,252 |
|
|
23,286 |
|
Aggregated funds payable |
|
|
17,092 |
|
|
9,659 |
|
Other accrued expenses |
|
|
11,521 |
|
|
10,923 |
|
Deferred revenue |
|
|
10,201 |
|
|
10,935 |
|
Current portion of long-term debt |
|
|
12,550 |
|
|
17,454 |
|
Related party current portion of long-term debt |
|
|
359 |
|
|
529 |
|
Current portion of operating lease liabilities |
|
|
5,412 |
|
|
4,398 |
|
Current portion of finance lease liabilities |
|
|
882 |
|
|
821 |
|
Total current liabilities |
|
|
133,109 |
|
|
123,489 |
|
Long-term liabilities |
|
|
|
|
|
|
|
Deferred tax liability |
|
|
101,294 |
|
|
174,480 |
|
Long-term debt, net, less current portion |
|
|
1,189,630 |
|
|
2,134,920 |
|
Related party long-term debt, net, less current portion |
|
|
32,125 |
|
|
64,758 |
|
Operating lease liabilities, net of current portion |
|
|
12,881 |
|
|
14,278 |
|
Finance lease liabilities, net of current portion |
|
|
11,522 |
|
|
12,194 |
|
Deferred revenue–LT |
|
|
5,652 |
|
|
6,173 |
|
Other long-term liabilities |
|
|
1,587 |
|
|
2,750 |
|
Total liabilities |
|
|
1,487,800 |
|
|
2,533,042 |
|
Commitments and contingencies (Note 19) |
|
|
|
|
|
|
|
Stockholders' equity |
|
|
|
|
|
|
|
Preferred stock |
|
|
— |
|
|
— |
|
Common stock |
|
|
1,721 |
|
|
1,217 |
|
Additional paid-in capital |
|
|
3,290,813 |
|
|
2,234,688 |
|
Accumulated other comprehensive income (loss) |
|
|
192 |
|
|
15,802 |
|
Accumulated deficit |
|
|
(239,979) |
|
|
(201,775) |
|
Total stockholders' equity |
|
|
3,052,747 |
|
|
2,049,932 |
|
Total liabilities and stockholders' equity |
|
$ |
4,540,547 |
|
$ |
4,582,974 |
|
Waystar Condensed Consolidated Statements of Cash Flows (in thousands, except for share and per share data) (unaudited) |
||||||
|
|
||||||
|
|
|
Nine months ended |
||||
|
|
|
2024 |
|
2023 |
||
|
Cash flows from operating activities |
|
|
|
|
|
|
|
Net loss |
|
$ |
(38,204) |
|
$ |
(36,919) |
|
Adjustments to reconcile net income/(loss) to net cash provided by operating activities |
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
148,635 |
|
|
131,780 |
|
Stock-based compensation |
|
|
47,400 |
|
|
6,505 |
|
Provision for bad debt expense |
|
|
1,642 |
|
|
1,614 |
|
Loss on extinguishment of debt |
|
|
20,277 |
|
|
— |
|
Deferred income taxes |
|
|
(57,984) |
|
|
(47,126) |
|
Amortization of debt discount and issuance costs |
|
|
3,301 |
|
|
7,907 |
|
Other |
|
|
(99) |
|
|
— |
|
Changes in: |
|
|
|
|
|
|
|
Accounts receivable |
|
|
(13,445) |
|
|
(5,101) |
|
Income tax refundable |
|
|
2,227 |
|
|
(619) |
|
Prepaid expenses and other current assets |
|
|
(1,714) |
|
|
(6,238) |
|
Deferred costs |
|
|
(14,389) |
|
|
(10,586) |
|
Other long-term assets |
|
|
(515) |
|
|
(33) |
|
Accounts payable and accrued expenses |
|
|
9,366 |
|
|
231 |
|
Deferred revenue |
|
|
(1,256) |
|
|
(257) |
|
Operating lease right-of-use assets and lease liabilities |
|
|
(244) |
|
|
(1,199) |
|
Other long-term liabilities |
|
|
— |
|
|
45 |
|
Net cash provided by operating activities |
|
|
104,998 |
|
|
40,004 |
|
Cash flows from investing activities |
|
|
|
|
|
|
|
Purchase of property and equipment and capitalization of internally developed software costs |
|
|
(21,044) |
|
|
(15,726) |
|
Acquisitions, net of cash and cash equivalents acquired |
|
|
— |
|
|
(30,027) |
|
Net cash used in investing activities |
|
|
(21,044) |
|
|
(45,753) |
|
Cash flows from financing activities |
|
|
|
|
|
|
|
Change in aggregated funds liability |
|
|
7,433 |
|
|
458 |
|
Proceeds from equity offering, net of underwriting discounts |
|
|
1,017,074 |
|
|
— |
|
Payments of third-party IPO issuance costs |
|
|
(3,372) |
|
|
— |
|
Repurchase of shares |
|
|
(844) |
|
|
(688) |
|
Proceeds from exercise of common stock options |
|
|
1,488 |
|
|
284 |
|
Proceeds from issuances of debt, net of creditor fees |
|
|
545,209 |
|
|
— |
|
Payments on debt |
|
|
(1,550,002) |
|
|
(13,487) |
|
Third-party fees paid in connection with issuance of new debt |
|
|
(1,410) |
|
|
— |
|
Finance lease liabilities paid |
|
|
(611) |
|
|
(599) |
|
Net cash provided by (used in) financing activities |
|
|
14,965 |
|
|
(14,032) |
|
Increase in cash and cash equivalents during the period |
|
|
98,919 |
|
|
(19,781) |
|
Cash and cash equivalents and restricted cash–beginning of period |
|
|
45,428 |
|
|
72,636 |
|
Cash and cash equivalents and restricted cash–end of period |
|
$ |
144,347 |
|
$ |
52,855 |
|
Supplemental disclosures of cash flow information |
|
|
|
|
|
|
|
Interest paid |
|
$ |
101,189 |
|
$ |
143,685 |
|
Cash taxes paid (refunds received), net |
|
|
38,558 |
|
|
36,654 |
|
Non-cash investing and financing activities |
|
|
|
|
|
|
|
Fixed asset purchases in accounts payable |
|
|
586 |
|
|
(502) |
|
Unpaid third-party IPO issuance costs |
|
|
50 |
|
|
— |
|
Reconciliation of Balance Sheet Cash Accounts to Cash Flow Statement |
|
|
|
|
|
|
|
Balance sheet |
|
|
|
|
|
|
|
Cash and cash equivalents |
|
|
127,125 |
|
|
44,450 |
|
Restricted cash |
|
|
17,222 |
|
|
8,405 |
|
Total |
|
|
144,347 |
|
|
52,855 |
|
Waystar Reconciliation of Adjusted EBITDA (in thousands) (unaudited) |
||||||||||||||||
|
|
||||||||||||||||
|
|
|
Three months ended |
|
Nine months ended |
||||||||||||
|
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|||||
|
Net income/(loss) |
|
$ |
5,413 |
|
|
$ |
(15,486) |
|
|
$ |
(38,204) |
|
|
$ |
(36,919) |
|
|
Interest expense |
|
|
18,459 |
|
|
|
52,410 |
|
|
|
126,184 |
|
|
|
153,057 |
|
|
Income tax expense/(benefit) |
|
|
3,274 |
|
|
|
(4,709) |
|
|
|
(17,398) |
|
|
|
(11,743) |
|
|
Depreciation and amortization |
|
|
60,185 |
|
|
|
43,675 |
|
|
|
148,635 |
|
|
|
131,780 |
|
|
Stock-based compensation expense |
|
|
7,903 |
|
|
|
2,207 |
|
|
|
47,400 |
|
|
|
6,505 |
|
|
Acquisition and integration costs |
|
|
188 |
|
|
|
1,342 |
|
|
|
696 |
|
|
|
3,236 |
|
|
Costs related to amended debt agreements |
|
|
106 |
|
|
|
- |
|
|
|
12,876 |
|
|
|
- |
|
|
IPO related costs |
|
|
109 |
|
|
|
1,551 |
|
|
|
2,114 |
|
|
|
1,554 |
|
|
Other (a) |
|
|
1,040 |
|
|
|
- |
|
|
|
1,040 |
|
|
|
- |
|
|
Adjusted EBITDA |
|
$ |
96,677 |
|
|
$ |
80,990 |
|
|
$ |
283,343 |
|
|
$ |
247,470 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue |
|
|
240,112 |
|
|
|
197,263 |
|
|
|
699,447 |
|
|
|
584,315 |
|
|
Net income/(loss) margin |
|
|
2.3 |
% |
|
|
(7.9) |
% |
|
|
(5.5) |
% |
|
|
(6.3) |
% |
|
Adjusted EBITDA margin |
|
|
40.3 |
% |
|
|
41.1 |
% |
|
|
40.5 |
% |
|
|
42.4 |
% |
|
|
|
|
(a) |
Adjustments relate to additional lease costs due to the relocation of our |
|
Waystar |
|
||||||||||||||||
|
Reconciliation of Non-GAAP Operating Expenses |
|
||||||||||||||||
|
(in thousands) |
|
||||||||||||||||
|
(unaudited)
|
|
||||||||||||||||
|
|
|
Three months ended |
|
|
Nine months ended |
||||||||||||
|
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
|||||
|
Cost of revenue (exclusive of depreciation and amortization expenses) |
|
$ |
80,545 |
|
|
$ |
62,922 |
|
|
$ |
236,188 |
|
|
$ |
182,578 |
|
|
|
Less: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense |
|
|
(300) |
|
|
|
(131) |
|
|
|
(2,161) |
|
|
|
(545) |
|
|
|
Acquisition and integration costs |
|
|
- |
|
|
|
(58) |
|
|
|
(31) |
|
|
|
(58) |
|
|
|
IPO related costs |
|
|
(4) |
|
|
|
- |
|
|
|
(9) |
|
|
|
- |
|
|
|
Cost of revenue (exclusive of depreciation and amortization expenses), adjusted |
|
$ |
80,241 |
|
|
$ |
62,733 |
|
|
$ |
233,987 |
|
|
$ |
181,975 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing |
|
$ |
38,450 |
|
|
$ |
32,114 |
|
|
$ |
117,945 |
|
|
$ |
93,490 |
|
|
|
Less: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense |
|
|
(1,587) |
|
|
|
(444) |
|
|
|
(10,958) |
|
|
|
(1,386) |
|
|
|
Acquisition and integration costs |
|
|
- |
|
|
|
(48) |
|
|
|
- |
|
|
|
(49) |
|
|
|
IPO related costs |
|
|
94 |
|
|
|
- |
|
|
|
(141) |
|
|
|
- |
|
|
|
Sales and marketing, adjusted |
|
$ |
36,957 |
|
|
$ |
31,622 |
|
|
$ |
106,846 |
|
|
$ |
92,055 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General and administrative |
|
$ |
22,704 |
|
|
$ |
17,365 |
|
|
$ |
88,794 |
|
|
$ |
46,524 |
|
|
|
Less: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense |
|
|
(4,832) |
|
|
|
(1,276) |
|
|
|
(27,043) |
|
|
|
(3,630) |
|
|
|
Acquisition and integration costs |
|
|
(86) |
|
|
|
(1,092) |
|
|
|
(272) |
|
|
|
(2,707) |
|
|
|
Costs related to amended debt agreements |
|
|
(106) |
|
|
|
- |
|
|
|
(12,876) |
|
|
|
- |
|
|
|
IPO related costs |
|
|
(200) |
|
|
|
(1,551) |
|
|
|
(1,956) |
|
|
|
(1,554) |
|
|
|
Other (a) |
|
|
(1,040) |
|
|
|
- |
|
|
|
(1,040) |
|
|
|
- |
|
|
|
General and administrative, adjusted |
|
$ |
16,440 |
|
|
$ |
13,446 |
|
|
$ |
45,607 |
|
|
$ |
38,633 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development |
|
$ |
11,082 |
|
|
$ |
8,972 |
|
|
$ |
37,303 |
|
|
$ |
25,548 |
|
|
|
Less: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense |
|
|
(1,184) |
|
|
|
(356) |
|
|
|
(7,238) |
|
|
|
(944) |
|
|
|
Acquisition and integration costs |
|
|
(102) |
|
|
|
(144) |
|
|
|
(393) |
|
|
|
(422) |
|
|
|
IPO related costs |
|
|
1 |
|
|
|
- |
|
|
|
(8) |
|
|
|
- |
|
|
|
Research and development, adjusted |
|
$ |
9,797 |
|
|
$ |
8,472 |
|
|
$ |
29,664 |
|
|
$ |
24,182 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
$ |
60,185 |
|
|
$ |
43,675 |
|
|
$ |
148,635 |
|
|
$ |
131,780 |
|
|
|
Less: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other (a) |
|
|
(15,776) |
|
|
|
- |
|
|
|
(15,776) |
|
|
|
- |
|
|
|
Depreciation and amortization, adjusted |
|
$ |
44,409 |
|
|
$ |
43,675 |
|
|
$ |
132,859 |
|
|
$ |
131,780 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense/(benefit) |
|
$ |
3,274 |
|
|
$ |
(4,709) |
|
|
$ |
(17,398) |
|
|
$ |
(11,743) |
|
|
|
Tax effect of adjustments |
|
|
5,276 |
|
|
|
1,071 |
|
|
|
16,779 |
|
|
|
2,372 |
|
|
|
Income tax expense/(benefit), adjusted |
|
$ |
8,550 |
|
|
$ |
(3,638) |
|
|
$ |
(619) |
|
|
$ |
(9,371) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
Adjustments relate to additional lease costs and accelerated depreciation due to the relocation of our |
|
Waystar |
|
|||||||||||||||||||||||||||||||||||
|
Reconciliation of Non-GAAP Net Income |
|
|||||||||||||||||||||||||||||||||||
|
(in thousands, except share and per share amounts) |
|
|||||||||||||||||||||||||||||||||||
|
(unaudited)
|
|
|||||||||||||||||||||||||||||||||||
|
|
|
Three months ended |
|
Nine months ended |
|
|||||||||||||||||||||||||||||||
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
|
||||||||||||||||||||||||
|
Net income/(loss) |
$ |
5,413 |
|
|
$ |
(15,486) |
|
|
$ |
(38,204) |
|
|
$ |
(36,919) |
|
|
||||||||||||||||||||
|
Stock-based compensation expense |
|
7,903 |
|
|
|
2,207 |
|
|
|
47,400 |
|
|
|
6,505 |
|
|
||||||||||||||||||||
|
Acquisition and integration costs |
|
188 |
|
|
|
1,342 |
|
|
|
696 |
|
|
|
3,236 |
|
|
||||||||||||||||||||
|
Costs related to amended debt agreements |
|
106 |
|
|
|
- |
|
|
|
12,876 |
|
|
|
- |
|
|
||||||||||||||||||||
|
IPO related costs |
|
109 |
|
|
|
1,551 |
|
|
|
2,114 |
|
|
|
1,554 |
|
|
||||||||||||||||||||
|
Other (a) |
|
16,816 |
|
|
|
- |
|
|
|
16,816 |
|
|
|
- |
|
|
||||||||||||||||||||
|
Tax effect of adjustments |
|
(5,276) |
|
|
|
(1,071) |
|
|
|
(16,779) |
|
|
|
(2,372) |
|
|
||||||||||||||||||||
|
Non-GAAP net income/(loss) |
$ |
25,259 |
|
|
$ |
(11,457) |
|
|
$ |
24,919 |
|
|
$ |
(27,996) |
|
|
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
Non-GAAP net income/(loss) per share, basic |
|
0.15 |
|
|
|
(0.09) |
|
|
|
0.18 |
|
|
|
(0.23) |
|
|
||||||||||||||||||||
|
Non-GAAP net income/(loss) per share, diluted |
|
0.14 |
|
|
|
(0.09) |
|
|
|
0.17 |
|
|
|
(0.23) |
|
|
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
Weighted-average shares used in computing basic non-GAAP net income/(loss) per share |
|
171,578,311 |
|
|
|
121,673,852 |
|
|
|
142,367,458 |
|
|
|
121,674,189 |
|
|
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
Weighted-average shares used in computing diluted non-GAAP net income/(loss) per share |
|
176,181,511 |
|
|
|
121,673,852 |
|
|
|
146,843,861 |
|
|
|
121,674,189 |
|
|
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
|
(a) |
Adjustments relate to additional lease costs and accelerated depreciation due to the relocation of our |
|
Waystar Reconciliation of Unlevered Free Cash Flow (in thousands) (unaudited) |
|||||||||||||||||
|
|
|||||||||||||||||
|
|
|
Three months ended |
|
Nine months ended |
|||||||||||||
|
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
|
||||
|
Net cash provided by operating activities |
|
$ |
78,818 |
|
|
$ |
(10,447) |
|
|
$ |
104,998 |
|
|
$ |
40,004 |
|
|
|
Interest paid |
|
|
18,925 |
|
|
|
49,037 |
|
|
|
101,189 |
|
|
|
143,685 |
|
|
|
Purchase of property and equipment and capitalization of internally developed software costs |
|
|
(8,616) |
|
|
|
(6,244) |
|
|
|
(21,044) |
|
|
|
(15,726) |
|
|
|
Unlevered free cash flow |
|
$ |
89,127 |
|
|
$ |
32,346 |
|
|
$ |
185,143 |
|
|
$ |
167,963 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Waystar |
|
|||||||
|
Reconciliation of Net Debt |
|
|||||||
|
(in thousands) |
|
|||||||
|
(unaudited)
|
|
|||||||
|
|
|
|
|
|
|
|
||
|
First lien term loan facility outstanding debt, current |
|
$ |
12,909 |
|
|
$ |
17,983 |
|
|
First lien term loan facility outstanding debt, net of current portion |
|
|
1,153,864 |
|
|
|
1,717,328 |
|
|
Second lien term loan facility outstanding debt |
|
|
- |
|
|
|
468,000 |
|
|
Receivables facility outstanding debt |
|
|
80,000 |
|
|
|
50,000 |
|
|
Cash and cash equivalents |
|
|
(127,125) |
|
|
|
(44,450) |
|
|
Net debt |
|
$ |
1,119,648 |
|
|
$ |
2,208,861 |
|
|
|
|
|
|
|
|
|
|
|
|
Trailing twelve months adjusted EBITDA |
|
$ |
369,587 |
|
|
$ |
325,755 |
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted gross leverage ratio |
|
|
3.4x |
|
|
|
6.9x |
|
|
Adjusted net leverage ratio |
|
|
3.0x |
|
|
|
6.8x |
|
|
Waystar Reconciliation of Trailing Twelve Months (TTM) Adjusted EBITDA (in thousands) (unaudited) |
|||||||||||||||||||||
|
|
|||||||||||||||||||||
|
|
Three Months Ended |
|
TTM |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
2024 |
|
|
2024 |
|
|
2024 |
|
|
2023 |
|
2024 |
|||||||||
|
Net income/(loss) |
$ |
5,413 |
|
|
$ |
(27,685) |
|
|
$ |
(15,932) |
|
|
$ |
(14,415) |
|
|
$ |
(52,619) |
|
||
|
Interest expense |
|
18,459 |
|
|
|
50,541 |
|
|
|
57,184 |
|
|
|
52,860 |
|
|
|
179,044 |
|
||
|
Income tax expense/(benefit) |
|
3,274 |
|
|
|
(14,611) |
|
|
|
(6,061) |
|
|
|
(757) |
|
|
|
(18,155) |
|
||
|
Depreciation and amortization |
|
60,185 |
|
|
|
44,276 |
|
|
|
44,174 |
|
|
|
44,686 |
|
|
|
193,321 |
|
||
|
Stock-based compensation expense |
|
7,903 |
|
|
|
36,969 |
|
|
|
2,528 |
|
|
|
2,343 |
|
|
|
49,743 |
|
||
|
Acquisition and integration costs |
|
188 |
|
|
|
206 |
|
|
|
302 |
|
|
|
711 |
|
|
|
1,407 |
|
||
|
Costs related to amended debt agreements |
|
106 |
|
|
|
2,368 |
|
|
|
10,402 |
|
|
|
393 |
|
|
|
13,269 |
|
||
|
IPO related costs |
|
109 |
|
|
|
1,841 |
|
|
|
164 |
|
|
|
423 |
|
|
|
2,537 |
|
||
|
Other (a) |
|
1,040 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
1,040 |
|
||
|
Adjusted EBITDA |
$ |
96,677 |
|
|
$ |
93,905 |
|
|
$ |
92,761 |
|
|
$ |
86,244 |
|
|
$ |
369,587 |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) |
Adjustments relate to additional lease costs due to the relocation of our |
Media Contact
kristin.lee@waystar.com
Investor Contact
investors@waystar.com
502-238-9511
View original content to download multimedia:https://www.prnewswire.com/news-releases/waystar-reports-third-quarter-2024-results-302297861.html
SOURCE Waystar
